RoboMed

RoboMed is a Finnish health technology startup focused on innovative medical diagnostics for gastrointestinal disorders.

The company is known for its flagship product, the Robotic Capsule, which offers a minimally invasive solution for predicting, diagnosing, and treating intestinal diseases. RoboMed has received funding to support its growth and was selected for the Health Incubator Helsinki program, providing mentorship and resources to enhance its technology and market presence. The Robotic Capsule is a swallowable device designed for capsule endoscopy, biopsy sampling, and microbiota analysis of the small intestine. It features a high-definition camera that streams images in real-time to a smartphone app, allowing for immediate detection of anomalies. The device also includes precise robotic biopsy needles for accurate tissue sampling, aiding in the diagnosis of conditions such as colorectal cancer and Crohn’s disease. This technology reduces the need for traditional invasive procedures, minimizing patient discomfort and recovery times while improving diagnostic accuracy.